SEC
Filing

SEC Filing Details

Document Details

Filing Date
Apr 30, 2018
Document Date
Dec 31, 2017
Form Description
Amendment to a previously filed 10-K
Filing Group
Annual Filings
Company
Altimmune
Issuer
ALTIMMUNE, INC.
 

Investor Contact

Richard Eisenstadt
Chief Financial Officer

Email: reisenstadt@altimmune.com

 

Email Alerts

Automatically receive Altimmune, Inc. financial information by e-mail

Subscribe